港股異動 | 利好疊加 中國有贊(8083.HK)大幅反彈逾20%
格隆匯4月4日丨中國有贊(8083.HK)大幅反彈20.38%,報0.189港元,成交額放大至5429萬港元,總市值34.8億港元。3月底公吿,公司2021年度收入15.7億元,毛利9.5億元,毛利率提升至60.7%。2022年公司首要經營目標為提升人均產出、改善經營現金流及經營結果。華泰證券點評稱,隨着有贊新零售的逐步推廣,認為門店SaaS或成為有贊訂閲解決方案業務的重要驅動力。維持“買入”評級。另外,3月31日獲執行董事崔玉松增持320萬股,涉資約51.84萬港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.